Date published: 2025-11-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

3-Deoxyglucosone (CAS 4084-27-9)

5.0(1)
Write a reviewAsk a question

See product citations (14)

Alternate Names:
3-Deoxy-D-erythro-hexulose; 2-Keto-3-deoxyglucose; D-3-Deoxyglucosone
Application:
3-Deoxyglucosone is an intermediate in the Maillard reaction of proteins with glucose
CAS Number:
4084-27-9
Purity:
95%
Molecular Weight:
162.14
Molecular Formula:
C6H10O5
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

3-Deoxyglucosone (3-DG) is an intermediate in the Maillard reaction of proteins with glucose, which is metabolised to 3-Deoxyfructose. It is involved in the synthesis of glycoproteins, glycosaminoglycans, and glycolipids, as well as in the regulation of gene expression and cell signaling. 3-Deoxyglucosone is also an intermediate in the formation of pyrraline, which might contribute to pathological effects, such as carcinogenesis.


3-Deoxyglucosone (CAS 4084-27-9) References

  1. Protein glycation: a firm link to endothelial cell dysfunction.  |  Wautier, JL. and Schmidt, AM. 2004. Circ Res. 95: 233-8. PMID: 15297385
  2. Pyridoxamine protects proteins from functional damage by 3-deoxyglucosone: mechanism of action of pyridoxamine.  |  Chetyrkin, SV., et al. 2008. Biochemistry. 47: 997-1006. PMID: 18161948
  3. Metabolism of 3-deoxyglucosone, an intermediate compound in the Maillard reaction, administered orally or intravenously to rats.  |  Kato, H., et al. 1990. Biochim Biophys Acta. 1035: 71-6. PMID: 2383581
  4. 3-Deoxyglucosone: a potential glycating agent accountable for structural alteration in H3 histone protein through generation of different AGEs.  |  Ashraf, JM., et al. 2015. PLoS One. 10: e0116804. PMID: 25689368
  5. Accumulation of intestinal tissue 3-deoxyglucosone attenuated GLP-1 secretion and its insulinotropic effect in rats.  |  Zhang, L., et al. 2016. Diabetol Metab Syndr. 8: 78. PMID: 27956941
  6. Formation of 3-deoxyglucosone in the malting process.  |  Nobis, A., et al. 2019. Food Chem. 290: 187-195. PMID: 31000036
  7. Dicarbonyl Stress at the Crossroads of Healthy and Unhealthy Aging.  |  Nigro, C., et al. 2019. Cells. 8: PMID: 31331077
  8. Alteration of Intestinal Microbiota in 3-Deoxyglucosone-Induced Prediabetic Rats.  |  Cai, J., et al. 2020. Biomed Res Int. 2020: 8406846. PMID: 32908918
  9. Pleiotropic Actions of Aldehyde Reductase (AKR1A).  |  Fujii, J., et al. 2021. Metabolites. 11: PMID: 34073440
  10. Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reaction.  |  Yamada, H., et al. 1994. J Biol Chem. 269: 20275-80. PMID: 8051120
  11. Monkey 3-deoxyglucosone reductase: tissue distribution and purification of three multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase, and aldose reductase.  |  Sato, K., et al. 1993. Arch Biochem Biophys. 307: 286-94. PMID: 8274014
  12. Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells. The involvement of reactive oxygen species formation and a possible implication for atherogenesis in diabetes.  |  Che, W., et al. 1997. J Biol Chem. 272: 18453-9. PMID: 9218489
  13. Beta2-Microglobulin dialysis amyloid and its formation: role of 3-deoxyglucosone and advanced glycation end products.  |  Niwa, T. 1997. Nephron. 76: 373-91. PMID: 9274834
  14. Overexpression of aldehyde reductase protects PC12 cells from the cytotoxicity of methylglyoxal or 3-deoxyglucosone.  |  Suzuki, K., et al. 1998. J Biochem. 123: 353-7. PMID: 9538214

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

3-Deoxyglucosone, 5 mg

sc-220865A
5 mg
$204.00

3-Deoxyglucosone, 10 mg

sc-220865
10 mg
$367.00

3-Deoxyglucosone, 25 mg

sc-220865B
25 mg
$736.00

3-Deoxyglucosone, 50 mg

sc-220865C
50 mg
$1336.00